Apexigen
Creating Transformative Immunotherapies for Patients with Cancer
11 employees · est. 2010 · San Carlos, United States
Onena Medicines
AI-centric preclinical company discovering and developing novel biopharmaceuticals to treat cancer and rare diseases
9 employees · est. 2019 · Basel, Switzerland
Apexigen is the older company (2010 vs 2019); Apexigen is the larger of the two.
Side-by-Side Comparison
| Metric | Apexigen | Onena Medicines |
|---|---|---|
| Founded | ||
| Founded | 2010 older | 2019 |
| Headquarters | ||
| Headquarters | San Carlos, United States | Basel, Switzerland |
| Employees | ||
| Employees | 11 larger | 9 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Medical Devices |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Unknown |
| Total Funding | ||
| Total Funding | $175.80M | $3.73M |
| Funding Rounds | ||
| Funding Rounds | 6 | 6 |
| Services | ||
| Services | Not tracked yet | Development of targeted antibody treatments |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical companies, Healthcare providers, Biotech investors |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Clinical-stage, Antibody Therapeutics, Immunotherapy, Cancer Treatment, Immuno-oncology, Sotigalimab, Phase 2 Clinical Development, Immune-activating Antibody, CD40, Cancer Immunotherapy, Oncology Drug Candidate | Biopharmaceuticals, Cancer Treatment, Rare Diseases, Antibody Drugs, Drug Discovery Platform, AI-centric Company, Preclinical Research, Oncology, Antibody Engineering, Clinical Development, Innovative Medicines, Orphan Illnesses, Switzerland |
| Website | ||
| Website | apexigen.com | onenameds.com |
About Apexigen
Apexigen is a clinical-stage biopharmaceutical company founded in 2010 with a focus on creating transformative immunotherapies for patients with cancer. The company is dedicated to discovering and developing a new generation of antibody therapeutics for the treatment of cancer, particularly emphasiz...
About Onena Medicines
Onena Medicines, founded in 2019 and headquartered in Switzerland, is a cutting-edge biopharmaceutical company focused on leveraging AI to discover and develop novel treatments for cancer and rare diseases. Their innovative pipeline includes first-in-class antibody medicines targeting a newly identi...
We will tell you when either one moves
BounceWatch watches Apexigen and Onena Medicines for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Apexigen and Onena Medicines — by email.
Frequently Asked Questions
Compare Apexigen with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Apexigen on 12 Sep 2024, and Onena Medicines on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.